Blog
About

0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      The Hemodynamic Effects of Practolol in Experimental Myocardial Infarction

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In order to study the circulatory effects of practolol in the depressed heart, myocardial infarction was produced in eight dogs by ligation of multiple coronary artery branches. Significant decreases in cardiac output, stroke volume, and left ventricular dp/dt, concomitant increases in systemic vascular resistance and left ventricular end-diastolic pressure occurred following ligation. The thoracic cavity was closed and the animals were allowed to stabilize their circulatory parameters. Practolol was then given in intravenous doses of 250, 500 and 1,000 µg/kg. These doses resulted in blood levels of 0.18, 0.30 and 0.62 µg/ml, without producing further deterioration of any of the hemodynamic variables that had been depressed by multiple coronary ligation. There was, however, a significant decrease in heart rate without a drop in cardiac output, which resulted in a slight but significant rise in stroke volume following practolol administration. Thus, it is concluded that practolol did not further reduce an already compromised heart in this model of acute infarction.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          1973
          1973
          29 October 2008
          : 58
          : 3
          : 181-189
          Affiliations
          Cardiology Division, Stanford University School of Medicine, Stanford, Calif.
          Article
          169632 Cardiology 1973;58:181–189
          10.1159/000169632
          4773537
          © 1973 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 9
          Categories
          Paper

          Comments

          Comment on this article